Market Access
We offer a full range of consulting services to meet today’s market access demands: health economics and outcomes research; value proposition development; landscape assessment; managed markets channel/product strategy; pricing and reimbursement support; and health technology assessment.
Market access is perhaps the most challenging issue facing the health care industry today. Globally, health care costs have outpaced economic growth. Aging populations and expectations of health have put enormous pressures on health care providers to manage the needs of patients. Yet, the rapid rise in overall health care expenditures has prompted regulators, policy makers, and payers to question the value of treatments, limit reimbursement, or withhold approval.
To succeed in this environment, lifesciences companies must develop a clear understanding of the needs and perspectives of the various stakeholders (e.g., public and private payers) in each individual market. Product innovation must demonstrate clear clinical and technological improvements while providing a compelling cost-effectiveness story. A thorough landscape assessment will not only reveal opportunities to communicate the value of a product that will be launched, but will also guide the development of the market access strategy.
|
|
Effective market access strategies need to define differentiated value propositions for each individual market. They must integrate pricing and reimbursement, outcomes research and health care economics, managed markets channel, and product strategy. To meet these demands, we offer a full complement of consulting services, each of which has a significant array of components for both domestic and international clients:
• Health economics and outcomes research
• Value proposition development
• Landscape assessment
• Managed markets channel/product strategy
• Pricing and reimbursement support
• Health technology assessment
|
